Medicamen Organics is preparing for its IPO scheduled to open on June 21 and close on June 25. The company aims to raise ₹10.54 crores through this NSE SME IPO. Medicamen Organics specializes in developing, manufacturing, and distributing various pharmaceutical formulations such as Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension, and Dry powders.

Their client base includes government institutions, private pharma companies, and international markets, facilitated through third-party distributors and contract manufacturing agreements. Recently, they have initiated direct exports to countries like Burundi, highlighting their strategic expansion efforts.

Medicamen IPO Profit Jumps: Medicamen Organics operates two WHO GMP-approved manufacturing facilities situated at 60 and 61, Sector 6A, I.I.E. SIDCUL, Ranipur, Haridwar, Uttarakhand, covering 21,536 sq. ft. These facilities are equipped to produce a wide range of pharmaceutical formulations and products. They boast a comprehensive quality control department staffed with experienced professionals, along with an in-house testing laboratory. The company holds ISO 9001:2015 certification, underscoring its commitment to quality management.

Their key strength lies in product development and documentation, enabling continuous research and development and the introduction of new products. This strategy not only diversifies their product lineup but also enhances their competitive pricing in the market. Their current portfolio comprises 84 products across various therapeutic categories such as Anti-Bacterial, Anti Diarrheal, Anti Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral, and Non-steroidal anti-inflammatory drugs (NSAIDS).

Medicamen IPO Profit Jumps: Medicamen Organics maintains a steady supply of high-quality products throughout the year, adhering strictly to safety standards. They prioritize quality assurance and are committed to expanding their product line by continuously seeking new and complementary products to enhance their offerings.

The objectives of the Medicamen Organics IPO proceeds are as follows:
1. Funding expenses related to product registration in international markets.
2. Upgrading plant facilities and increasing production capacity.
3. Meeting working capital requirements.
4. General corporate purposes.

The IPO details are as follows:
– IPO Open Date: June 21, 2024
– IPO Close Date: June 25, 2024
– IPO Size: Approximately ₹10.54 crores, offering 3,100,000 equity shares
– Face Value: ₹10 per equity share
– Price Band: ₹32 to ₹34 per equity share
– Listing Exchange: NSE SME
– Retail Quota: 35% of the net offer
– QIB Quota: 50% of the net offer
– NII Quota: 15% of the net offer

For more details, refer to the DRHP and RHP draft prospectuses, and information on anchor investors can be found on their respective documents.

The Medicamen Organics IPO offers a minimum market lot of 4000 shares requiring an application amount of ₹136,000. The IPO is scheduled to open on June 21, 2024, and close on June 25, 2024.

The basis of allotment is set for June 26, 2024, with refunds and credit to demat accounts expected by June 27, 2024. The IPO listing date is anticipated to be June 28, 2024. For updates on IPO subscription status and allotment, please visit the relevant pages.

Medicamen IPO Profit Jumps: To apply for the Medicamen Organics IPO, investors can use the ASBA (Application Supported by Blocked Amount) facility available in their bank accounts.

Simply log in to your online banking portal, navigate to the ‘Invest’ section, and select the Medicamen Organics IPO for application. Alternatively, IPO application forms can be downloaded from the BSE website, filled out, and submitted either at your bank branch or through your broker.

Regarding financial performance, Medicamen Organics reported the following figures in crore rupees:
– Year 2021: Revenue ₹25.06, Expenses ₹24.57, PAT ₹0.30
– Year 2022: Revenue ₹21.19, Expenses ₹20.93, PAT ₹0.09
– Year 2023: Revenue ₹22.96, Expenses ₹21.60, PAT ₹0.96
– September 2023: Revenue ₹11.33, Expenses ₹9.57, PAT ₹1.29

For the fiscal year 2023, key financial metrics include:
– Earnings Per Share (EPS): ₹1.60 per Equity Share
– Return on Net Worth (RoNW): 11.25%
– Net Asset Value (NAV): ₹14.20 per Equity Share

Medicamen Organics operates within a peer group that includes companies like Brooks Laboratories Ltd, Cian Healthcare Ltd, and Zenotech Laboratories Ltd.

Medicamen Organics IPO is an NSE SME IPO aimed at raising ₹10.54 Crores. The IPO price band is set at ₹32 to ₹34 per equity share, with plans for listing on NSE. The IPO opens on June 21, 2024, and is accessible to QIB, NII, and Retail Investors.

Investor allocations for the IPO are as follows: QIB – 50%, NII – 15%, and Retail – 35%.

To apply for the Medicamen Organics IPO, investors have several options:

1. ASBA Online via Bank Account or UPI:
– Apply online through your bank’s ASBA facility by logging into your net banking account and selecting the Medicamen Organics IPO.
– Alternatively, use UPI through your stockbroker’s platform to apply online.

2. Offline Application via Stockbroker:
– Fill out the offline IPO application form provided by your stockbroker.

Specifically for different platforms:

Zerodha:
– Log in to Zerodha’s Console or Application.
– Navigate to the IPO section under Portfolio.
– Select “Medicamen Organics” and click on the Bid button.
– Enter your UPI ID, quantity of shares, and price.
– Submit the IPO application form and approve the mandate in your UPI app.

Upstox:
– Log in to the Upstox application.
– Select the IPO section and find “Medicamen Organics”.
– Click on the Bid button to confirm your application.
– Approve the mandate in your UPI app.

Paytm Money:
– Log in to the Paytm Money app.
– Select the IPO section and choose “Medicamen Organics”.
– Click on the Bid button to confirm your application.
– Approve the mandate in your UPI app.

Key IPO Details:
– IPO Size: ₹10.54 crores
– Price Band: ₹32 to ₹34 per equity share
– Minimum Lot Size: 4000 shares (₹136,000)
– Allotment Date: June 26, 2024
– Listing Date: June 28, 2024 on NSE SME

Investors can check the official IPO details for updates and monitor the grey market premium on relevant platforms for daily updates.